Cargando…

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia

Detalles Bibliográficos
Autores principales:	Leucht, Stefan, Davis, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803798/ https://www.ncbi.nlm.nih.gov/pubmed/35038002 http://dx.doi.org/10.1007/s00406-021-01378-1

Ejemplares similares

Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
por: Leucht, Stefan, et al.
Publicado: (2021)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Has Research Informed Us on the Practical Drug Treatment of Schizophrenia?
por: Davis, John M., et al.
Publicado: (2008)

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
por: Pae, Chi-Un
Publicado: (2020)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

S235. MAINTENANCE TREATMENT WITH ANTIPSYCHOTIC DRUGS IN SCHIZOPHRENIA – SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

O7.3. DOSE-RESPONSE META-ANALYSIS TO IDENTIFY THE OPTIMUM AND EQUIVALENT DOSES OF ANTIPSYCHOTIC DRUGS FOR SCHIZOPHRENIA
por: Leucht, Stefan, et al.
Publicado: (2018)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

T216. VARIATION IN SIDE EFFECTS TO ANTIPSYCHOTIC TREATMENT ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS
por: Susanne Neumeier, Maria, et al.
Publicado: (2020)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2022)

Repurposing Antipsychotics for Cancer Treatment
por: Vlachos, Nikolaos, et al.
Publicado: (2021)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
por: Cheng, Zhang, et al.
Publicado: (2020)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Siafis, Spyridon, et al.
Publicado: (2023)

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
por: Tajika, Aran, et al.
Publicado: (2023)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
por: Huhn, Maximilian, et al.
Publicado: (2020)

Attitudes Towards Antipsychotics Among Patients with Schizophrenia on First- or Second-Generation Medications
por: Karthik, M. S., et al.
Publicado: (2014)

T6. SECOND GENERATION ANTIPSYCHOTIC DRUGS AND MORTALITY: A META-ANALYSIS OF PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIALS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia
por: Taipale, Heidi, et al.
Publicado: (2022)

Which treatment modality should we choose for advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2010)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Which antipsychotics can we use for obsessive-compulsive symptoms in schizophrenia?
por: Aissa, A., et al.
Publicado: (2021)

A Growing Evil Which Should Be Remedied
Publicado: (1892)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2019)

Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study
por: De Hert, Marc, et al.
Publicado: (2011)

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
por: Pu, Chengcheng, et al.
Publicado: (2020)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
por: Płaza, Olga, et al.
Publicado: (2022)

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
por: Schneider-Thoma, Johannes, et al.
Publicado: (2021)

Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective
por: Přikryl, Radovan, et al.
Publicado: (2012)

Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
por: Bahta, Merhawi, et al.
Publicado: (2021)

Choosing an Optimal Antipsychotic Dose for Relapse Prevention
por: Davis, John M, et al.
Publicado: (2022)

Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment
por: Li, Wenbin, et al.
Publicado: (2018)

Should psychiatrists be more cautious about the use of antipsychotics for patients with borderline personality disorder?
por: Damiano, Rodolfo Furlan, et al.
Publicado: (2022)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

First-generation antipsychotics: not gone but forgotten
por: Dibben, Claire R. M., et al.
Publicado: (2016)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qolvdkde3nk1botrufu20bail9